A marker for personalised feedback on dieting: Angiotensin Converting Enzyme

Shilpa Tejpal, Narinder Sanghera, Vijayalaxmi Manoharan, Joan Planas-Iglesias, Judith Klein‐SeetharamanProceedings of The Nutrition Society 2019 · DOI

Abstract

Obesity is a rising global epidemic associated with metabolic disorders such as diabetes and insulin resistance. While dietary plans and exercise are standard weight loss options, achieving and maintaining weight loss is challenging, often leading to demoralization when results are not immediately visible. Current technology tracks calorie intake but lacks a direct biological link to immediate weight loss progress. This study identifies Angiotensin Converting Enzyme (ACE) as a potential quantitative, science-based biomarker that responds to caloric restriction within a 24-hour interval, offering a biological feedback loop to sustain dieter motivation.

Introduction

The primary hurdle in weight loss is the "laggy" feedback loop. Traditional scales often fail to reflect a single day of caloric restriction due to water retention and metabolic noise, which can discourage individuals. While wearables track activity, there is a critical need for a biological marker that confirms a physiological response to dieting in real-time. This research explores whether ACE levels can serve as a high-frequency metabolic sensor to provide the personalized reinforcement necessary for long-term behavioral change.

Methods

The study monitored 47 participants (mean BMI 27 ± 5) over a 24-hour dietary intervention.

  • Dietary Protocol: Participants adhered to a 1,200 Kcal diet, with an optional snack of less than 250 Kcal.
  • Data Collection: An in-house digital health platform logged food intake and physical activity. Urine samples were collected to measure ACE concentrations.
  • Biochemical Analysis: ACE levels were quantified using a Human ACE DuoSet ELISA (Enzyme-Linked Immunosorbent Assay).
  • Statistical Analysis: Pearson correlations and Mann-Whitney U tests were performed using R to evaluate the relationship between ACE fluctuations, BMI, and weight change.

Key Results and Insights

The study demonstrated that ACE levels are dynamic enough to reflect caloric restriction within a 24-hour window, shifting its clinical utility from a static cardiovascular marker to a real-time metabolic indicator.

BMI-Specific Sensitivity

The correlation between ACE levels and weight loss was significantly more robust in individuals with a BMI > 25. A clear linear trend was observed in this group, reinforcing its potential as a reliable metric for overweight and obese populations.

Figure 1: Positive correlation between BMI and ACE levels recorded on the day following caloric restriction (R² = 0.292, p = 0.015).

Predictive Power in Female Participants

In female participants, specific ACE metrics were strong predictors of weight loss. The "minimum ACE amount" recorded during the 24-hour window showed a strong negative correlation with weight lost ($R^2 = -0.453, p = 0.034$), meaning a lower "ACE floor" was associated with greater weight reduction. Additionally, the following day's ACE concentration positively correlated with weight difference ($R^2 = 0.482, p = 0.031$).

Figure 2: Scatter plots illustrating the relationship between weight difference and (top) minimum ACE levels and (bottom) following-day ACE levels in female participants.

Discussion and Limitations

These findings propose ACE as the "biological engine" for a new generation of health technology that moves beyond simple calorie counting toward biological response monitoring. However, several limitations remain:

  • Scale and Duration: The 24-hour study duration and small sample size (n=47) necessitate longer-term validation to ensure these correlations persist over weeks or months.
  • Accessibility: ELISA testing is currently laboratory-bound. For ACE to function as a personalized feedback tool, it must be integrated into portable, point-of-care devices (e.g., urine-based test strips).
  • Mechanistic Depth: Further research is required to fully elucidate the physiological pathways linking rapid caloric deficits to ACE fluctuations and to rule out confounding factors like hydration.

Conclusion

ACE represents a promising biomarker for providing immediate, science-based feedback to individuals on a weight loss journey. By closing the feedback loop within 24 hours, ACE-based monitoring could significantly improve adherence and outcomes in obesity management.

Summary updated

Abstract

Obesity is a worldwide rising epidemic disease and is associated with metabolic disorders such as diabetes and insulin resistance (1) . Exercise, drugs, surgery and/or dietary plans are typical weight loss options that are offered/follow to lose weight However, achieving weight loss is hard work and failure is demoralising. Technology supported devices allow to record calorie consumption but relationship no direct link to weight loss There is a need of a devise that could be more directly linked to weight loss. There is first need of identification of a quantitative and science-based biomarker of weight loss that has the potential to provide a biological feedback loop to the dieter. Angiotensin Converting Enzyme (ACE) has been identified as a potential marker for weight loss To keep individuals motivated, there is a need to focus on providing feedback over a 24-hour interval. Here, we aim to understand the use of ACE as an early marker for weight loss.
BibTeX
@inproceedings{tejpal2019marker,
  author = {Shilpa Tejpal and Narinder Sanghera and Vijayalaxmi Manoharan and Joan Planas-Iglesias and Judith Klein‐Seetharaman},
  title = {{A marker for personalised feedback on dieting: Angiotensin Converting Enzyme}},
  booktitle = {Proceedings of The Nutrition Society},
  year = {2019},
  doi = {10.1017/s0029665119000703},
}
Figure